The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology.
OBJECTIVE
Children and adolescents with chronic kidney disease (CKD) are at high risk for cardiovascular morbidity and mortality. A systemic arteriopathy and cardiomyopathy has been characterized in pediatric dialysis patients by the presence of morphologic and functional abnormalities.


METHODS
The Cardiovascular Comorbidity in Children with CKD (4C) Study is a multicenter, prospective, observational study aiming to recruit more than 600 children, aged 6 to 17 years, with initial GFR of 10 to 45 ml/min per 1.73 m(2). The prevalence, degree, and progression of cardiovascular comorbidity as well as its association with CKD progression will be explored through longitudinal follow-up. The morphology and function of the heart and large arteries will be monitored by sensitive noninvasive methods and compared with aged-matched healthy controls. Multiple clinical, anthropometric, biochemical, and pharmacologic risk factors will be monitored prospectively and related to the cardiovascular status. A whole-genome association study will be performed to identify common genetic variants associated with progression of cardiovascular alterations and/or renal failure. Monitoring will be continued as patients reach end-stage renal disease and undergo different renal replacement therapies.


RESULTS
While cardiovascular morbidity in adults is related to older age and additional risk factor load (e.g., diabetes), the role of CKD-specific factors in the initiation and progression of cardiac and vascular disease are likely to be characterized with greater sensitivity in the pediatric age group.


CONCLUSIONS
The 4C study is expected to provide innovative insight into cardiovascular and renal disease progression in CKD.
Querfeld
Uwe
U
Department of Pediatric Nephrology, Charité Universitätsmedizin Berlin CVK, Augustenburger Platz 1, 13353 Berlin, Germany. uwe.querfeld@charite.de
Anarat
Ali
A
Bayazit
Aysun K
AK
Bakkaloglu
Aysin S
AS
Bilginer
Yelda
Y
Caliskan
Salim
S
Civilibal
Mahmut
M
Doyon
Anke
A
Duzova
Ali
A
Kracht
Daniela
D
Litwin
Mieczyslaw
M
Melk
Anette
A
Mir
Sevgi
S
Sözeri
Betül
B
Shroff
Rukshana
R
Zeller
René
R
Wühl
Elke
E
Schaefer
Franz
F
D000293:Adolescent; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics; D016022:Case-Control Studies; D002648:Child; D002908:Chronic Disease; D015897:Comorbidity; D018450:Disease Progression; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D005919:Glomerular Filtration Rate; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics / Q000503:physiopathology; D011379:Prognosis; D011446:Prospective Studies; D012107:Research Design; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors